argenx SE (EBR: ARGX)
Belgium
· Delayed Price · Currency is EUR
604.60
+4.80 (0.80%)
Dec 20, 2024, 5:36 PM CET
argenx SE Employees
argenx SE had 1,148 employees as of December 31, 2023. The number of employees increased by 305 or 36.18% compared to the previous year.
Employees
1,148
Change (1Y)
305
Growth (1Y)
36.18%
Revenue / Employee
€1,490,683
Profits / Employee
€31,469
Market Cap
36.50B
Employees Chart
argenx SE News
- 4 days ago - Biohaven Advances in Immunotherapy: Significant IgG Reduction Achieved with BHV-1300, Gains Analyst Approval - Benzinga
- 26 days ago - argenx to Present at Upcoming Investor Conferences - GlobeNewsWire
- 4 weeks ago - argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies - GlobeNewsWire
- 4 weeks ago - Steritas Announces Collaboration with argenx to Advance Evidence for Novel Steroid-sparing Therapeutics - Business Wire
- 5 weeks ago - (ARGX) - Analyzing argenx's Short Interest - Benzinga
- 5 weeks ago - This Bristol-Myers Squibb Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday - Benzinga
- 5 weeks ago - Argenx upgraded at Wolfe on myasthenia gravis dominance - Seeking Alpha
- 5 weeks ago - argenx and Zai Lab Announce Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy in China - GlobeNewsWire